Literature DB >> 21909621

Tophus gout and chronic kidney disease in a young female patient: report of familial juvenile hyperuricemic nephropathy in three generations of the same family.

Marta M C Medeiros1, Geraldo B Silva, Elizabeth F Daher.   

Abstract

A 20-year-old female was admitted with tophus gout and chronic kidney disease (CKD), progressing to dialysis need and death. The familial investigation evidenced several cases of hyperuricemia, gout and CKD, as well as several cases of early death due to CKD. After analyzing these cases, it was concluded that the diagnosis was familial juvenile hyperuricemic nephropathy. This is an autosomal dominant disorder caused by mutations in the uromodulin gene, characterized by early beginning hyperuricemia and gout, in men and women, associated with progressive CKD.

Entities:  

Mesh:

Year:  2011        PMID: 21909621     DOI: 10.1007/s00296-011-2106-5

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  15 in total

1.  Gout, familial hypericaemia, and renal disease.

Authors:  H DUNCAN; A S DIXON
Journal:  Q J Med       Date:  1960-01

2.  Characterization and separation of an inhibitor of viral hemagglutination present in urine.

Authors:  I TAMM; F L HORSFALL
Journal:  Proc Soc Exp Biol Med       Date:  1950-05

Review 3.  Tamm-Horsfall protein--uromodulin (1950-1990).

Authors:  S Kumar; A Muchmore
Journal:  Kidney Int       Date:  1990-06       Impact factor: 10.612

4.  Pathophysiology of Tamm-Horsfall protein.

Authors:  J R Hoyer; M W Seiler
Journal:  Kidney Int       Date:  1979-09       Impact factor: 10.612

5.  Effects of urinary macromolecules on hydroxyapatite crystal formation.

Authors:  Ann M Beshensky; Jeffrey A Wesson; Elaine M Worcester; Elena J Sorokina; Carl J Snyder; Jack G Kleinman
Journal:  J Am Soc Nephrol       Date:  2001-10       Impact factor: 10.121

6.  A novel pattern of mutation in uromodulin disorders: autosomal dominant medullary cystic kidney disease type 2, familial juvenile hyperuricemic nephropathy, and autosomal dominant glomerulocystic kidney disease.

Authors:  Xosé M Lens; Julio F Banet; Patricia Outeda; Vicente Barrio-Lucía
Journal:  Am J Kidney Dis       Date:  2005-07       Impact factor: 8.860

7.  Renal handling of urate in a patient with familial juvenile gouty nephropathy.

Authors:  I Hisatome; H Kosaka; K Ohtahara; M Tsuboi; I Manabe; A Ohtahara; M Sawaguchi; O Igawa; Y Tanaka; Y Fujimoto; A Yoshida; A Takeda; C Shigemasa
Journal:  Intern Med       Date:  1996-07       Impact factor: 1.271

8.  Presymptomatic detection of familial juvenile hyperuricaemic nephropathy in children.

Authors:  M B McBride; S Rigden; G B Haycock; N Dalton; W Van't Hoff; L Rees; G V Raman; F Moro; C S Ogg; J S Cameron; H A Simmonds
Journal:  Pediatr Nephrol       Date:  1998-06       Impact factor: 3.714

Review 9.  Uromodulin storage diseases: clinical aspects and mechanisms.

Authors:  Francesco Scolari; Gianluca Caridi; Luca Rampoldi; Regina Tardanico; Claudia Izzi; Doroti Pirulli; Antonio Amoroso; Giorgio Casari; Gian Marco Ghiggeri
Journal:  Am J Kidney Dis       Date:  2004-12       Impact factor: 8.860

10.  Allelism of MCKD, FJHN and GCKD caused by impairment of uromodulin export dynamics.

Authors:  Luca Rampoldi; Gianluca Caridi; Daniela Santon; Francesca Boaretto; Ilenia Bernascone; Giuseppe Lamorte; Regina Tardanico; Monica Dagnino; Giacomo Colussi; Francesco Scolari; Gian Marco Ghiggeri; Antonio Amoroso; Giorgio Casari
Journal:  Hum Mol Genet       Date:  2003-10-21       Impact factor: 6.150

View more
  4 in total

1.  Association of kidney disease with prevalent gout in the United States in 1988-1994 and 2007-2010.

Authors:  Stephen P Juraschek; Lara C Kovell; Edgar R Miller; Allan C Gelber
Journal:  Semin Arthritis Rheum       Date:  2013-01-09       Impact factor: 5.532

2.  Identification of a novel UMOD mutation (c.163G>A) in a Brazilian family with autosomal dominant tubulointerstitial kidney disease.

Authors:  L B Lopes; C C Abreu; C F Souza; L E R Guimaraes; A A Silva; F Aguiar-Alves; K O Kidd; S Kmoch; A J Bleyer; J R Almeida
Journal:  Braz J Med Biol Res       Date:  2018-03-01       Impact factor: 2.590

3.  Urate-lowering therapy for gout and asymptomatic hyperuricemia in the pediatric population: a cross-sectional study of a Japanese health insurance database.

Authors:  Masataka Honda; Hideki Horiuchi; Tomoko Torii; Akihiro Nakajima; Takeshi Iijima; Hiroshi Murano; Hisashi Yamanaka; Shuichi Ito
Journal:  BMC Pediatr       Date:  2021-12-18       Impact factor: 2.125

4.  Prevalence of gout and asymptomatic hyperuricemia in the pediatric population: a cross-sectional study of a Japanese health insurance database.

Authors:  Shuichi Ito; Tomoko Torii; Akihiro Nakajima; Takeshi Iijima; Hiroshi Murano; Hideki Horiuchi; Hisashi Yamanaka; Masataka Honda
Journal:  BMC Pediatr       Date:  2020-10-15       Impact factor: 2.125

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.